Boehringer Ingelheim España SA in Consumer Health (Spain)

March 2015 | 3 pages | ID: BA4F40FDABAEN
Euromonitor International Ltd

Abstracts

Boehringer Ingelheim’s efforts are focused more on developing the Rx market than on consumer health. In the former field the company is redirecting its efforts towards areas such as anticoagulation and diabetes. An important strategic area is oncology, in which it has important research activity, with many cancer trials in Spain. It plans to launch products in the next 10 years for diseases such as diabetes, COPD, asthma and IPF (idiopathic pulmonary fibrosis).

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric OTC Healthcare, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Boehringer Ingelheim España SA: Key Facts
Summary 2 Boehringer Ingelheim España SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Boehringer Ingelheim España SA: Competitive Position 2014